Nuvation Bio Inc. (NUVB) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$173.43M | -33.0% |
| 2024 | -$130.41M | -91.8% |
| 2023 | -$68.00M | +29.2% |
| 2022 | -$96.11M | -40.9% |
| 2021 | -$68.19M | -86.7% |
| 2020 | -$36.53M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$173.43M | -33.0% |
| 2024 | -$130.41M | -91.8% |
| 2023 | -$68.00M | +29.2% |
| 2022 | -$96.11M | -40.9% |
| 2021 | -$68.19M | -86.7% |
| 2020 | -$36.53M | — |